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Abstract
Aims: The objective of this study is to describe alcohol consumption behaviors of young adults 
with T1D and to examine associations between alcohol consumption and diabetes-related clinical 
markers
Methods: Data from 602 SEARCH for Diabetes in Youth Study participants age ≥18 yrs. with 
T1D were collected from 12/2011 to 6/2015 (50% female, mean age 21.3(SD 2.4), 22% race/
ethnic minority). Participants were characterized as alcohol non-drinkers (n=269), drinkers but 
non-binge drinkers (n=167), or binge drinkers (n=166) based on reported consumption in the past 
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30 days. Analyses were conducted using one-way ANOVAs, chi-square tests, and logistic 
regression modeling to examine associations between drinking and clinical markers.
Results: Fifty-five percent of participants reported alcohol consumption; 27.6% of participants 
reported binge drinking. After adjusting for demographic characteristics, neither binge drinking 
nor non-binge drinking were associated with HbA1c or severe hypoglycemic events relative to 
non-drinkers. Binge drinking was associated with higher HDL (p=0.008), lower systolic blood 
pressure (p-=0.011), and a lower waist:height ratio compared to non-drinkers (p=0.013).
Conclusions: Young adults with T1D in the SEARCH cohort reported similar alcohol use but 
higher rates of binge drinking compared to the general United States population and previously 
reported rates in adults with T1D.
Keywords
type 1 diabetes; alcohol; binge drinking
Introduction
Type 1 diabetes (T1D) is a chronic disease caused by the autoimmune disruption of 
endogenous insulin secretion. Typically diagnosed in childhood, T1D requires careful 
management during adolescence and emerging young adulthood, as deterioration of 
metabolic control is common during this life stage. Data from the T1D Exchange 
demonstrates a sharp incline in HbA1c after the age of 10, peaking at the age of 19 years, 
and then slowly declining to reach a plateau at age 30 years1. Hormonal changes 
compounded by increasing desire for autonomy and the strict requirements of proper self-
management make adolescence a uniquely difficult time to maintain good glycemic control2. 
As a result, complications and comorbidities of T1D are prevalent in adolescents and young 
adults diagnosed with T1D in childhood3.
Alcohol use, is common in young adults.4 Data suggests that adults with type 1 diabetes 
consume alcohol at similar rates to the general population5. In a recent report from the T1D 
Exchange study, 79% of adult participants with T1D (average age of 38 years), reported 
using alcohol in the past year, 63% in the past month, and 9% reported daily use5; 19% of 
participants were classified as binge drinkers in this cohort.
In the current study, we aimed to describe the drinking behaviors of young adults with T1D, 
and the associations of drinking, including non-binge and binge drinking, on clinical 
parameters such as HbA1c, severe hypoglycemia events, and cardiovascular (CV) risk 
markers including lipid profile, blood pressure, BMI and waist-to-height ratio (WHTR). 
Glycemic control and cardiovascular risk factors (lipid profile, blood pressure, BMI, 
WHTR) were examined as they relate to development of microvascular and macrovascular 
complications of T1D3. Severe hypoglycemia was chosen as a clinical variable given the 
association of alcohol use with acute and subacute hypoglycemia6.
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Materials and Methods
SEARCH for Diabetes in Youth (SEARCH) is an ongoing multicenter population-based 
study of physician-diagnosed diabetes mellitus in youth <20 years of age. Participants were 
identified in geographically defined populations in Colorado, Ohio, South Carolina, and 
Washington, among health plan enrollees in California, and Indian Health Service 
beneficiaries from American Indian populations. A detailed description of the SEARCH 
study and methods has been published7.
Institutional review boards for each site approved the study protocol. Informed consent and 
assent were obtained from participants at the start of the visit. SEARCH participants with 
type 1 diabetes diagnosed in 2002–2006 and 2008 who had a baseline study visit and at least 
5 years duration of diabetes were invited to participate in a follow up in-person study visit 
(Cohort visit). Individuals with incident diabetes in 2007 were not eligible for an in-person 
visit, and thus were excluded from analysis.
Research visits
Self-report demographic data was collected, including Race, ethnicity, education and 
income. Race/ethnicity was categorized into non-Hispanic white (NHW) and other racial/
ethnic groups which combined Hispanic (regardless of race), African American, American 
Indian and Asian/Pacific Islander into one category8. Diabetes self-management and number 
of severe hypoglycemia episodes in the prior 6 months were obtained at the Cohort visit. 
Anthropomorphic measurements were taken and BMI was defined as weight (kilograms) 
divided by height (meters2) and converted to a Z score9. Waist-to-height ratio (WHTR) was 
measured using National Health and Nutrition Examination Survey (NHANES) 
methodology. Three resting systolic and diastolic blood pressure levels were taken and an 
average was calculated. Blood was drawn after an 8-h overnight fast, and medications, 
including short-acting insulin, were withheld until after the blood was drawn on the morning 
of the visit.
Laboratory measures
Specimens were analyzed for GAD-65 antibodies (GAD65)10 and insulinoma-associated-2 
antibodies (IA-2A) as well as Fasting lipids, HbA1c, and glucose11 at the Northwest Lipid 
Metabolism and Diabetes Research Laboratory (Seattle, WA) and Zinc-Transporter 8 
autoantibody12 was analyzed at the Eisenbarth laboratory (University of Colorado, Aurora, 
CO).
Surveys
Participants filled out a series of questionnaires at the cohort visit. The alcohol use survey 
included alcohol-related questions from the 2011 CDC behavior risk factor surveillance 
system (BRFSS) questionnaires13. On the alcohol use survey, participants were classified as 
drinkers if they responded “yes” to the question “During the past 30 days, have you had at 
least one drink of any alcoholic beverage such as beer, wine, a malt beverage or liquor?” If 
participants gave a response of “no” to this question, then they were classified as non-
drinkers. Those who responded “don’t know” or “I don’t want to answer” were excluded 
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from these analyses. Per the standard National Institute on Alcohol Abuse and Alcoholism 
binge drinking definition, binge drinking was based on the largest number of drinks on any 
occasion within the past 30 days; with a threshold of 5 or more for males and 4 or more for 
females14.
Participants who had smoked within the past 30 days were categorized as current tobacco 
users, with former tobacco users being defined as not having smoked within the past 30 days 
but having ever tried smoking a cigarette. Participants were categorized as physically active 
if they exercised or participated in a physical activity for at least 20 minutes that made them 
sweat and breathe hard at least 3 days per week. Sedentary behavior was defined separately 
and was classified as watching 2 or more hours of television or electronic screens per 
weekday. Depressive symptoms were measured using the Center for Epidemiologic Studies 
Depression Scale (CES-D)15,16. Quality of life was assessed using the PedsQL Generic 
Core, with scores ranging from 0–100, higher scores indicating higher quality of life17. 
Participants were categorized as having one or more episodes of severe hypoglycemia if they 
responded “yes” to the question “In the past 6 months, have you had any severe 
hypoglycemia, that is, very low blood sugar that required you to get help?” and “If yes, how 
many times?”.
Data Analysis
These analyses were restricted to the following inclusion criteria: participants in the cohort 
visit who had type 1 diabetes, had a positive GAD65, ZnT8 and/or IA2 result at their 
baseline visit and were at least 18 years of age and taking insulin at the time of their cohort 
visit. Initial analysis included participants ages 12–18 at the cohort visit but this age group 
was not included in final analyses due to the low prevalence of drinking (5.7%).
Descriptive analyses present means and standard deviations for continuous measures and 
counts and percentages for categorical variables. Bivariate tests were conducted using one-
way ANOVAs and chi-square tests. Multivariable multinomial logistic regression was 
conducted using a generalized logit function to compute odds ratios and 95% confidence 
intervals for drinkers vs. non-drinkers and binge drinkers vs. non-drinkers. General linear 
models and logistic regression models, both unadjusted and adjusted, were constructed in 
order to describe the relationship between drinking status and HbA1c (as a continuous 
variable), number of severe hypoglycemic events over the past 6 months, and CVD risk 
markers. Covariates not significant in univariate models were not included in multivariable 
models. All analyses were conducted using SAS v 9.4 and use a 0.05 level of significance.
Results
Of the 3863 individuals eligible for the SEARCH cohort visit, 2777 (71.9%) participated. A 
total of 602 participants met inclusion criteria as described above, and were included in 
these analyses. Of these participants, 269 (44.7%) were non-drinkers, and 167 (27.7%) were 
non-binge drinkers, and 166 (27.6%) were binge drinkers (Table 1). The mean number of 
days per month at least 1 drink was consumed was 3.29 (SD 5.2) and mean number of drinks 
per drinking occasion was 2.07 (SD 3.4). The study sample was evenly split between males 
and females with an average age of 21.3 years at the time of the first cohort visit. A majority 
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of the study sample was non-Hispanic white (78.1%), came from a two-parent household 
(68.8%) with at least one parent having education beyond high school (81.8%). Almost a 
third (28.8%) of participants came from households earning USD $75,000 or greater, while 
the remainder of participants were split fairly evenly across the lower household income 
divisions. Less than half of participants reported healthy lifestyle habits, including never 
having used tobacco (48.8%) and being physically active (49.5%), watching less than 2 
hours of television on weekdays (41.0%) and engaging in diabetes self-management, 
including checking blood sugar four or more times daily (48.2%); 46.2% used an insulin 
pump. Overall glycemic control of study participants was suboptimal, with a mean HbA1c 
of 9.1% (SD 2.0).
There was no sex differences for overall rate of drinkers vs. non-drinkers. However, males 
consumed alcohol more frequently (7.3 days v. 4.5 days, p<0.0001) and consumed more 
alcoholic drinks per occasion (4.7 drinks vs. 3.0 drinks, p=0.0001) compared to females. 
Additionally, males were more likely to be binge drinkers as compared to females (34.2% 
vs. 20.9%, p= 0.0003). Additionally, males were more likely than females to be smokers 
(current or former) than non-smokers (OR 1.6, 95% CI=1.1–2.2).
Participants who were 21 years old or older were more likely to have consumed alcohol in 
the past 30 days (77.1% vs. 36.5%, p<0.0001) and drank more frequently (7.0 days vs. 4.0 
days out of the last 30 days, p<0.0001) compared to those participants ages 18–20 years. 
The 21 and older age group was also more likely to be binge drinkers (41.6% vs. 15.5%, 
p<0.0001), but average number of drinks consumed per occasion did not differ between age 
groups. A small number of participants reported use of other medications (in addition to 
insulin); no significant differences were seen when looking at alcohol consumption 
behaviors by medication use.
In the adjusted models, comparing binge drinkers to non-drinkers (Table 2), binge drinkers 
were older (OR 1.4, 95% CI = 1.2–1.6), had higher parental education (OR 2.6, 95% CI = 
1.4–4.8), and were more likely to be current (OR 10.5, 95% CI =5.8–19.2) or former (OR 
5.8, 95% CI = 3.3–10.1) tobacco users compared to nondrinkers.
In adjusted models comparing non-binge drinkers to non-drinkers, non-binge drinkers were 
older (OR 1.3, 95% CI = 1.1–1.5), had a higher parental education (OR 2.2, 95% CI =1.2–
4.0), and were more likely to be current (OR 2.4, 95% CI =1.3–4.3) or former (OR 2.5, 95% 
CI = 1.5–4.2) tobacco users compared to non-drinkers.
When comparing binge drinkers to non-binge drinkers, binge drinkers were more likely to 
be male (OR 2.0, 95% CI =1.3–3.2) and current (OR 4.5, 95% CI = 2.4–8.2) or former (OR 
2.3, 95% CI = 1.3–4.0) tobacco users compared to non-binge drinkers.
Relationships between alcohol consumption and clinical markers were examined and the 
model was adjusted for sex, age at diagnosis, age at cohort visit, race/ethnicity, highest 
parental education, and tobacco use (Table 3). Binge drinking was associated with higher 
HDL compared to non-drinkers (B = 4.16, SE = 1.57, p=0.0082) or non-binge drinkers 
(B=4.14, SE=1.56, p=0.0081), lower systolic blood pressure (SBP) compared to non-
drinkers (B=−0.34, SE=0.14, p=0.0113) or non-binge drinkers (B=−0.30, SE=0.14, 
Roberts et al. Page 5
Diabetes Res Clin Pract. Author manuscript; available in PMC 2021 January 01.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
p=0.0259), and a lower weight-to-height ratio (WHTR) compared to non-drinkers (B=−0.02, 
SE=0.01, p=0.0134). Binge drinking was not associated with adverse glycemic outcomes 
(HbA1c) or severe hypoglycemic events. There were no differences in alcohol consumption 
behaviors by SEARCH site, nor were there site differences in associations of alcohol use 
with clinical markers.
When stratified by physical activity, among the physically active, binge drinkers were more 
likely to have higher SBP than non-drinkers (B=0.89, SE=0.27, p=0.001) with no 
relationship in the physically inactive. WHTR was lower in binge drinkers compared to non-
drinkers in the physically inactive group (B=−0.03, SE=0.01, p=0.016) with no relationship 
in the physically active. HDL differences were not significant when stratified by physical 
activity.
When stratified by insulin pump use, among pump users, non-binge drinkers had a higher 
HbA1c than non-drinkers (B=0.48, SE=0.22, p=0.032), but binge drinkers had a lower 
HbA1c than non-binge drinkers (B=−0.70, SE=0.25, p= 0.006). Among non-pump users, 
binge drinkers had a higher HDL compared to non-binge drinkers (B=5.47, SE=2.20, 
p=0.014). SBP was lower in binge drinkers vs. non-drinkers (B=−0.43, SE=0.19, p=0.023) 
and non-binge drinkers (B=−0.41, SE=0.20, p=0.040).
Discussion
This report from the SEARCH study demonstrates that alcohol consumption and binge 
drinking are common behaviors among young adults with T1D. The legal age for alcohol 
consumption in the USA is 21 years, which likely explains the low prevalence of drinking in 
the 12–18 year old SEARCH participants who were excluded from final analysis. Rates of 
binge drinking were especially high in this young adult cohort compared to rates found in 
other adult (older) T1D cohorts: in T1D Exchange (mean age of participants was 38 years), 
19% reported binge drinking5, while we found a substantially higher rate of binge drinking 
(27%) with participants’ mean age of 21.4 years. This is the first study that we know of that 
examined alcohol consumption rates in this young adult T1D population. Our findings are 
consistent with trends seen in the non-T1D young adult USA population, in that college-age 
rates of binge drinking are high in the USA, quoted as 30–40%18. Binge drinking rates are 
higher in those who attend college and in males18. This is consistent with our findings that 
males with T1D consumed alcohol more frequently, more alcohol per occasion, and were 
more likely to be binge drinkers than females with T1D. The legal age for alcohol 
consumption in the USA is 21 years, which likely explains the low prevalence of reported 
drinking in the 12–18 year old SEARCH participants who were excluded from final 
analysis.
We were unable to examine how employment and educational status may impact these 
findings, for instance, if participants who attended college were more likely to report binge 
drinking. We did find that binge drinkers had a higher parental education level compared to 
non-drinkers, and college attendance status could explain this association. Reported 
household income was not significantly different between drinking status groups, thus socio-
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economic status does not explain the associations we found with higher parental education 
level.
Among USA college students, non-Hispanic Whites demonstrate higher rates of binge 
drinking, compared to Hispanic or African American students18. We did not find 
associations with drinking patterns and race/ethnicity in our T1D population.
Alcohol consumption and binge drinking were more often observed in current or former 
tobacco users in our T1D population. This association of alcohol use with tobacco use has 
been well-described in the general USA population19.
The literature is mixed on the association of alcohol and glycemic control. While some 
studies have demonstrated that both liberal and moderate consumption of alcohol by 
individuals with T1D had no significant effect on serum glucose levels,20,21 others have 
shown increased hypoglycemic response to alcohol consumption, though no severe 
hypoglycemic events were observed.6,22 In a multicenter analysis of the German/Austrian 
DPV registry of youth and young adults with T1D, any alcohol use was associated with 
worse glycemic control, more severe hypoglycemia, and increased DKA rates23. However, 
in our study we did not observe any significant associations between alcohol consumption 
and HbA1c or self-reported number of severe hypoglycemic events over the past 6 months in 
adjusted models. The DPV registry study included a younger cohort- ages 12–29 years, 
average age 17.0 years, compared to our young adult, ≥18 year old cohort. Only 10.8% of 
their younger cohort reported alcohol use, representing a small subset of young patients who 
likely had other risk factors for DKA and poor glycemic control. Thus, it is difficult to 
compare our findings to their study given the very different age distribution and 
developmental stages. A recent study in Italy demonstrated that among youth (age 13–19 
years) with T1D alcohol use was associated with increased abdominal adiposity, 
dyslipidemia, and poor adherence to the Mediterranean diet, as well as higher HbA1c24. 
Similar to the DPV registry study, only 10% of youth in the Italian study reported alcohol 
consumption, thus making their findings difficult to compare with our study for the reasons 
mentioned above.
Alcohol consumption by individuals with T1D can be associated with acute concerns, 
mainly increased hypoglycemia risk during, and for 24 hours following consumption6. In 
our study, the rate of severe hypoglycemia was similar to that reported in other studies of 
young adults with T1D25, but low (overall 9.0%) and thus we were not adequately powered 
to detect associations between severe hypoglycemia with alcohol use. Alcohol use also may 
be associated with more chronic concerns such as risk for CV disease or microvascular 
complications, though these relationships remain unclear. Light to moderate alcohol 
consumption (one to three drinks a day) has been associated with favorable cardiovascular 
risk profile and reductions in cardiovascular death and nonfatal myocardial infarction26. 
Binge drinking, however, demonstrates an increase in mortality, hypertension27, alcoholic 
cardiomyopathy, cancer, and cerebrovascular events26. When looking specifically at adults 
with T1D, no association was found between alcohol consumption and coronary artery 
calcification as a marker of cardiovascular risk28.
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In earlier studies of individuals with T1D, alcohol consumption has either not been 
associated with microvascular disease or has been protective. Some studies show that 
moderate consumption is associated with no change in risk of proliferative retinopathy29, 
neuropathy30, and macroalbuminuria29,31 while other studies show a decreased risk in these 
complications with moderate consumption31.
In our cohort, we found that binge drinking was associated with favorable cardiovascular 
markers including higher HDL, lower SBP, and lower WHTR. This may be related to the 
young age of our cohort in that the detrimental effects of binge drinking on CV risk factors 
may take time to develop, as well the lack of ability to control for college/occupational 
status in this study. When stratified by age, the 21–23 year old age group was found to drive 
the binge drinking association with SBP and WHTR. When stratified by physical activity, 
physical activity did not drive the associations found in the adjusted model.
However, regardless of direct relationships between alcohol use and diabetes specific 
complications, alcohol is a high-risk activity that can contribute to morbidity and mortality 
in this population. A Norwegian nationwide mortality study looking at deaths in those with 
T1D, found 20% of deceased misused alcohol and 15% of those with T1D that died had 
alcohol related ICD-10 codes on their death certificate32. The cause of death was associated 
with alcohol in 21.8% of those who died with less than 20 years’ diabetes duration.
There are some limitations to this study. Since data on drinking behavior was dependent on 
self-report, there is a potential for response bias and recall bias, especially considering that 
drinking behavior can often be perceived as a sensitive topic by participants. Other self-
report variables are subject to response bias as well. Self-report is also limited by recall bias 
when asking participants to recall drinking behaviors over the prior 30 days. The effect of 
this bias would likely be toward the null, yet statistically significant findings did emerge in 
our study. Another limitation is the relatively short duration of follow-up for our 
participants, such that we can only report the short-term effects. As mentioned previously, 
we did not have employment or student status for our participants to be able to control for 
this as a variable. An important strength of this study is that while drinking patterns may 
vary by geographic region and demographic groups, this research benefits from being able to 
draw from the large, diverse SEARCH for Diabetes in Youth cohort.
Conclusions
This study demonstrates that young adults with T1D engage in alcohol consumption in a 
pattern that is similar to other individuals in their age group without diabetes, and many 
engage excessively. While there were no measurable adverse association between alcohol 
consumption in the short-term and glycemic control and CVD risk factors in the SEARCH 
cohort, the German/Austrian DPV registry data23 and Norwegian mortality study32 suggest 
that there are substantial acute and long-term risks of alcohol consumption in T1D. Given 
these previously reported risks, and the high alcohol consumption and binge-drinking rates 
in young adults with T1D, counselling and education around alcohol use and its potential 
consequences should be incorporated into the care of young adults with T1D.
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Table 1:
Characteristics of 602 Adult Participants in the SEARCH Cohort Visit
Overall n=602 Binge drinkers 
n=166
Non-binge 
drinkers n=167
Non-drinkers 
n=269
Chi 
Square P-
value
Male N(%) 301 (50.0) 103 (62.0) 71 (42.5) 127 (47.2) 0.001
Age at diagnosis 
Mean(SD)
12.9 (2.6) 13.4 (2.3) 13.7 (2.8) 12.0 (2.4) < 0.001
Age at cohort visit 
(years) Mean(SD)
21.3 (2.4) 22.1 (2.2) 22.1 (2.7) 20.3 (2.0) < 0.001
Duration (years) 
Mean(SD)
8.4 (1.8) 8.6 (1.7) 8.4 (1.9) 8.2 (1.8) 0.093
Race/ethnicity N(%) Hispanic and/or 
nonwhite
132 (21.9) 24 (14.5) 31 (18.6) 77 (28.6) 0.001
Non-hispanic white 470 (78.1) 142 (85.5) 136 (81.4) 192 (71.4)
Highest parental 
education N(%)
<= High school 108 (18.2) 23 (14.0) 22 (13.4) 63 (23.9) 0.006
> High school 484 (81.8) 141 (86.0) 142 (86.6) 201 (76.1)
Household income 
N(%)
<$25K 95 (15.9) 28 (17.0) 25 (15.1) 42 (15.7) 0.864
$25–49K 96 (16.1) 27 (16.4) 26 (15.7) 43 (16.1)
$50–74K 84 (14.0) 22 (13.3) 25 (15.1) 37 (13.9)
$75K+ 172 (28.8) 52 (31.5) 51 (30.7) 69 (25.8)
DK/Ref 151 (25.3) 36 (21.8) 39 (23.5) 76 (28.5)
Tobacco use N(%) Current 137 (23.0) 69 (42.1) 34 (20.6) 34 (12.7) < 0.001
Former 168 (28.2) 63 (38.4) 59 (35.8) 46 (17.2)
Never 291 (48.8) 32 (19.5) 72 (43.6) 187 (70.0)
Physically active 
N(%)a
298 (49.5) 90 (54.2) 81 (48.5) 127 (47.2) 0.349
Sedentary behavior 
N(%)b
354 (59.0) 103 (62.4) 93 (55.7) 158 (59.0) 0.459
Household N(%) 2 Parents / 1 
Household
411 (68.8) 114 (68.7) 116 (69.9) 181 (68.3) 0.941
Other 186 (31.2) 52 (31.3) 50 (30.1) 84 (31.7)
How often blood sugar 
checked N(%)
Less than 4 times per 
day
310 (51.8) 96 (57.8) 88 (52.7) 126 (47.5) 0.111
4 or more times per 
day
288 (48.2) 70 (42.2) 79 (47.3) 139 (52.5)
Insulin regimen N(%) Pump 278 (46.2) 61 (36.7) 90 (53.9) 127 (47.2) 0.156
Long + short/rapid 
insulin, 3 or more 
times a day
137 (22.8) 42 (25.3) 33 (19.8) 62 (23.0)
Long + any other 
combination, 2 or 
more times a day
132 (21.9) 47 (28.3) 30 (18.0) 55 (20.4)
Any combination of 
insulins excluding 
long, 3 or more times 
a day
37 (6.1) 12 (7.2) 9 (5.4) 16 (5.9)
Any insulins taken 
once a day, or any 
18 (3.0) 4 (2.4) 5 (3.0) 9 (3.3)
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Overall n=602 Binge drinkers 
n=166
Non-binge 
drinkers n=167
Non-drinkers 
n=269
Chi 
Square P-
value
insulin combination 
except long 2 times a 
day
Continuous Glucose 
Monitor Use N(%)
93 (15.8) 25 (15.5) 27 (16.5) 41 (15.6) 0.965
HbA1c Mean(SD) 9.1 (2.0) 8.8 (2.0) 9.1 (2.0) 9.2 (2.0) 0.103
Severe Hypoglycemia 
N(%)
54 (9.0) 21 (12.7) 15 (9.0) 18 (6.7) 0.107
CESD score Mean(SD) 10.6 (9.1) 10.6 (9.5) 9.8 (9.0) 11.0 (9.1) 0.431
PQOL total score 
(child) Mean(SD)
83.3 (12.9) 82.7 (13.2) 83.6 (12.7) 83.4 (12.9) 0.799
SBP z-score Mean(SD) 0.2 (1.9) 0.3 (1.8) 0.7 (2.1) −0.2 (1.6) < 0.001
DBP z-score Mean(SD) −0.2 (2.9) −0.8 (3.1) 0.1 (3.6) −0.0 (2.1) 0.007
total cholesterol 
(mg/dL) Mean(SD)
171.8 (38.5) 169.5 (35.2) 171.7 (35.7) 173.3 (42.0) 0.617
HDL cholesterol 
(mg/dL) Mean(SD)
54.5 (14.1) 55.8 (15.0) 53.9 (13.9) 54.1 (13.6) 0.411
LDL cholesterol 
(mg/dL) Mean(SD)
97.7 (29.7) 93.7 (25.9) 98.8 (29.2) 99.3 (32.0) 0.135
triglycerides (mg/dL) 
Mean(SD)
100.0 (93.5) 101.6 (81.2) 95.7 (74.9) 101.8 (109.7) 0.783
a
Physically active defined as: participating in a physical activity for ≥20 minutes a day, ≥3 days a week
bSedentary behavior defined as: ≥2 hours of screen time per weekday
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Table 2:
Adjusted odds ratio (aOR) and 95% confidence interval (CI) for alcohol consumption by demographic and 
clinical characteristics
Binge drinker vs. Non-
drinker
Non-binge drinker vs. Non-
drinker
Binge drinker vs. Non-
binge drinker
aOR (95% 
CI) P Value
aOR (95% 
CI) P Value
aOR (95% 
CI) P Value
P value 
(overall 
test)
Male Gender 1.4 (0.9–2.2) 0.159 0.7 (0.5–1.1) 0.104 2.0 (1.3–3.2) 0.003 0.012
Age at diagnosis 
(years)
1.0 (0.9–1.2) 0.817 1.1 (1.0–1.3) 0.114 0.9 (0.8–1.1) 0.220 0.249
Age at cohort visit 
(years)
1.4 (1.2–1.6) < 0.001 1.301 <0.001 1.1 (0.9–1.2) 0.489 < 0.001
Race/ethnicity: 
Other
0.8 (0.4–1.5) 0.476 0.8 (0.5–1.4) 0.412 1.0 (0.5–1.9) 0.983 0.648
Parent with > 
High school 
education (ref: 
High school or 
less)
2.6 (1.4–4.8) 0.003 2.2 (1.2–4.0) 0.010 1.2 (0.6–2.3) 0.647 0.004
Tobacco use (ref: 
Never)
Current 10.5 (5.8–
19.2)
< 0.001 2.4 (1.3–4.3) 0.005 4.5 (2.4–8.2) < 0.001 < 0.001
Former 5.8 (3.3–10.1) < 0.001 2.5 (1.5–4.2) <0.001 2.3 (1.3–4.0) 0.004
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Table 3:
Relationship between alcohol consumption and clinical characteristics
*Adjusted for sex, age at diagnosis, age at cohort visit, race/ethnicity, parental education, and tobacco use
Unadjusted Adjusted*
Outcome Drinking Beta (SE) P Value
P Value 
(Overall) Beta (SE) P Value
P Value 
(Overall)
HBA1C Binge drinker vs. non-drinker −0.42 (0.20) 0.034 0.103 −0.27 (0.21) 0.201 0.158
Non-binge drinker vs. non-drinker −0.12 (0.20) 0.526 0.13 (0.20) 0.506
Binge drinker vs. non-binge drinker −0.29 (0.22) 0.179 −0.40 (0.21) 0.057
Total cholesterol Binge drinker vs. non-drinker −3.78 (3.85) 0.327 0.617 −2.07 (4.31) 0.631 0.884
Non-binge drinker vs. non-drinker −1.62 (3.82) 0.671 −1.37 (4.04) 0.735
Binge drinker vs. non-binge drinker −2.16 (4.27) 0.614 −0.70 (4.28) 0.871
HDL cholesterol Binge drinker vs. non-drinker 1.65 (1.41) 0.243 0.411 4.16 (1.57) 0.008 0.011
Non-binge drinker vs. non-drinker −0.21 (1.40) 0.883 0.020 (1.47) 0.989
Binge drinker vs. non-binge drinker 1.85 (1.56) 0.236 4.14 (1.56) 0.008
LDL cholesterol Binge drinker vs. non-drinker −5.67 (3.00) 0.056 0.135 −5.60 (3.38) 0.098 0.204
Non-binge drinker vs. non-drinker −0.52 (2.94) 0.860 −0.63 (3.17) 0.842
Binge drinker vs. non-binge drinker −5.15 (3.29) 0.117 −4.97 (3.36) 0.140
Triglycerides Binge drinker vs. non-drinker −0.21 (9.35) 0.983 0.783 −4.41 (10.80) 0.683 0.868
Non-binge drinker vs. non-drinker −6.09 (9.28) 0.512 −4.99 (10.13) 0.622
Binge drinker vs. non-binge drinker 5.88 (10.37) 0.571 0.58 (10.74) 0.957
Systolic blood 
pressure
Binge drinker vs. non-drinker 0.50 (0.18) 0.006 < 0.001 −0.34 (0.14) 0.011 0.025
Non-binge drinker vs. non-drinker 0.98 (0.18) < 0.001 −0.04 (0.13) 0.741
Binge drinker vs. non-binge drinker −0.48 (0.20) 0.017 −0.30 (0.14) 0.026
Diastolic blood 
pressure
Binge drinker vs. non-drinker −0.77 (0.28) 0.007 0.007 −0.10 (0.26) 0.698 0.720
Non-binge drinker vs. non-drinker 0.12 (0.28) 0.672 0.11 (0.24) 0.655
Binge drinker vs. non-binge drinker −0.89 (0.31) 0.005 −0.21 (0.26) 0.420
BMI Binge drinker vs. non-drinker −0.17 (0.09) 0.074 0.151 −0.13 (0.11) 0.214 0.459
Non-binge drinker vs. non-drinker 0.00 (0.09) 0.983 −0.05 (0.10) 0.620
Binge drinker vs. non-binge drinker −0.17 (0.10) 0.103 −0.08 (0.11) 0.435
NHANES 
WHTR
Binge drinker vs. non-drinker −0.02 (0.01) 0.005 0.015 −0.02 (0.01) 0.013 0.043
Non-binge drinker vs. non-drinker 0.00 (0.01) 0.641 −0.01 (0.01) 0.123
Binge drinker vs. non-binge drinker −0.02 (0.01) 0.033 −0.01 (0.01) 0.302
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